NCT05848167

Brief Summary

Osteoporotic fracture is one of the main causes of disability and death in elderly patients. Specific disease cohort study is an important basis for accurate prevention and treatment of senile osteoporotic fractures. Investigators plan to collect and manage the baseline and clinical information of more than 2000 elderly patients with osteoporotic fractures after surgery through the platform of special disease collaborative prevention and treatment system and medical record database of Suzhou Municipal Hospital in two years, and carry out short-term and long-term follow-up observation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2021

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

April 26, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 8, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 14, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 14, 2024

Completed
Last Updated

November 22, 2023

Status Verified

November 1, 2023

Enrollment Period

2.8 years

First QC Date

April 26, 2023

Last Update Submit

November 20, 2023

Conditions

Osteoporotic Fractures

Keywords

Senile osteoporotic fracture,Cohort study,mechanism,outcome

Outcome Measures

Primary Outcomes (1)

  • Bone mineral density

    BMD

    two years

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

Elderly patients after operation of osteoporotic fracture.

You may qualify if:

  • Patients ≥65 years old
  • Patients with osteoporosis
  • No gender limitation

You may not qualify if:

  • \< 65 years old;
  • Non-osteoporotic fracture;
  • Alzheimer's disease;
  • Bone tumors.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Suzhou Municipal Hospital

Suzhou, Jiangsu, 215000, China

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

serum

MeSH Terms

Conditions

Osteoporotic Fractures

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and Injuries

Study Officials

  • Hao Y feng, doctor

    Suzhou Municipal Hospital

    STUDY CHAIR

Central Study Contacts

Hao Y feng, doctor

CONTACT

1391310933913913109339@163.com

Che Y jun, doctor

CONTACT

19941919699cheyanjun1980@hotmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

April 26, 2023

First Posted

May 8, 2023

Study Start

July 15, 2021

Primary Completion

May 14, 2024

Study Completion

July 14, 2024

Last Updated

November 22, 2023

Record last verified: 2023-11

Locations

CN(1)